TF and non-small cell lung carcinoma: To begin to investigate the potential involvement of TF in disease progression and therapy resistance, we first examined CCLE NSCLC cell line database and found elevated TF mRNA in large percentage of KRASmut NSCLC cell lines (Fig. 2A).